ONEGENE PROGRAM
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90695869
- Registration number
- 7270239
- Mark type
- Word mark
- Filed
- 07 May 2021
- Published for opposition
- 22 Feb 2022
- Registered
- 09 Jan 2024
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 035 — Advertising and business services: Business administration of a patient assistance program for providing prescription drugs at reduced cost
- Class 036 — Insurance and financial services: Providing information regarding insurance coverage and reimbursement for prescription drugs; financial administration of a patient assistance program for providing prescription drugs at reduced cost
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Nov 2023 — ASSIGNED TO LIE
- 07 Nov 2023 — ASSIGNED TO EXAMINER
- 23 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 May 2023 — NON-FINAL ACTION E-MAILED
- 23 May 2023 — SU - NON-FINAL ACTION - WRITTEN
- 02 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Apr 2023 — USE AMENDMENT FILED
- 01 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL